Small Molecule Radiopharmaceuticals- A Review of Current Approaches
Shubhra eChaturvedi, Anil Kumar Mishra
Frontiers in Medicine · 2016
doi:10.3389/fmed.2016.00005 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
AbstractRadiopharmaceuticals are an integral component of nuclear medicine and are widely applied in diagnostics and therapy. Though widely applied, the development of an ideal radiopharmaceutical can be challenging. Issues like specificity, selectivity, sensitivity and feasible chemistry challenge the design and synthesis of radiopharmaceuticals. Over time, strategies to address the issues have evolved by making use of new technological advances in the fields of biology and chemistry. This review presents the application of few advances in design and synthesis of radiopharmaceuticals. The topics covered are bivalent ligand approach and lipidizationas part of design modifications for enhanced selectivity and sensitivity and novel synthetic strategies for optimized chemistry and radiolabeling of radiopharmaceuticals.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.